The Supreme Court has raised serious questions about the significant price discrepancies in the prices of medicines used to treat serious diseases like cancer. The court heard a case in which the Price to Retail (PTR) of a cancer drug was reported as Rs 2,700, while the MRP was Rs 27,000. This means there was a nearly 10-fold difference between the retail price and the MRP. A two-judge bench of the Supreme Court expressed serious concern over this discrepancy and asked why there was no price con